Regenerative Medicine News
Nobel Prize-Winner’s Stem Cells Help Glaxo Pinpoint Risks
October 24, 2012 - (Bloomberg) - "GlaxoSmithKline Plc (GSK) is applying Shinya Yamanaka’s Nobel Prize-winning discovery in stem cells to identify heart risks linked to experimental drugs earlier in the development process." Read Full Article
Posted on
13-Nov-12
by Gallerno, Jacob
Tags:
Science and Industry News
Trackback Url
|
Link to this post
| Bookmark this post with:
